<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0142513</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-33868</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Environmental Polychlorinated Biphenyl Exposure and Breast Cancer Risk: A Meta-Analysis of Observational Studies</article-title>
<alt-title alt-title-type="running-head">PCB Exposure and Breast Cancer Risk</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Jingwen</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Huang</surname>
<given-names>Yue</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Xiaoling</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lin</surname>
<given-names>Kun</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Wu</surname>
<given-names>Kusheng</given-names>
</name>
<xref rid="cor001" ref-type="corresp">*</xref>
<xref rid="aff001" ref-type="aff"/>
</contrib>
</contrib-group>
<aff id="aff001"><addr-line>Department of Preventive Medicine, Shantou University Medical College, Shantou, Guangdong, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Lehmler</surname>
<given-names>Hans-Joachim</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>The University of Iowa, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: KW JZ. Performed the experiments: JZ YH XW KL KW. Analyzed the data: JZ. Contributed reagents/materials/analysis tools: JZ YH XW. Wrote the paper: JZ.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">kswu@stu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>11</issue>
<elocation-id>e0142513</elocation-id>
<history>
<date date-type="received">
<day>2</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Zhang et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0142513" xlink:type="simple"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Association between polychlorinated biphenyl (PCB) exposure and breast cancer risk has been widely studied, but the results remain controversial. We performed a meta-analysis to evaluate the evidences from observational studies on PCB exposure and breast cancer risk.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>Relevant studies with data on internal PCB dose were identified from PubMed, EMBASE, CBM and CNKI databases through November 2014. Multivariable-adjusted odds ratio (OR) with 95% confidence intervals (CIs) were applied to assess the association between PCB exposure and breast cancer risk. Heterogeneity test, sensitivity analysis, subgroup analysis and publication bias test were also performed. To further explore the association between specific groups of PCB congeners and breast cancer, we examined the PCB congeners classified, according to their structural, biological and pharmacokinetics properties, as group I (potentially estrogenic), group II (potentially anti-estrogenic and immunotoxic, dioxin-like), and group III (phenobarbital, CYP1A and CYP2B inducers, biologically persistent).</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Of 660 studies screened, 25 studies which met criteria were selected, involving a total of 12866 participants (6088 cases and 6778 controls) from eight countries. The results showed that the risk of breast cancer was associated with group II (OR = 1.23, 95% CI: 1.08–1.40) and group III (OR = 1.25, 95% CI: 1.09–1.43) PCBs, but not with group I (OR = 1.10, 95%CI: 0.97–1.24) PCBs or total PCB exposure (OR = 1.09, 95%CI: 0.97–1.22).</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>Our meta-analysis based on the selected studies found group II and group III PCB exposure might contribute to the risk of breast cancer. More studies in developing countries with higher PCB levels are needed, as well as studies to explore the relationships between mixtures of organochlorine compounds and breast cancer risk.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>This work was supported by the National Natural Science Foundation of China (no.: 81470152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="3"/>
<page-count count="18"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability" xlink:type="simple">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Breast cancer is the most common cancer among women in the world, there were nearly 1.67 million new cancer cases diagnosed (25% of all cancers) in 2012 and a slight majority of cases occurred in women in developing countries [<xref rid="pone.0142513.ref001" ref-type="bibr">1</xref>]. During the recent past, the rapid rising incidence of breast cancer in developing countries suggested that ongoing environmental change might be a primary contributor [<xref rid="pone.0142513.ref002" ref-type="bibr">2</xref>]. The association between breast cancer risk and industrial development, historically and worldwide, is one indicator of modifiable risk [<xref rid="pone.0142513.ref003" ref-type="bibr">3</xref>]. Risk factors for breast cancer can be classified into four broad categories: genetic/familial, reproductive/hormonal, lifestyle, and environmental. However, these known risk factors explain only a small fraction of cases. More and more studies indicate that the effects of hormones and environmental factors are becoming increasingly important as breast cancer risk factors [<xref rid="pone.0142513.ref004" ref-type="bibr">4</xref>–<xref rid="pone.0142513.ref007" ref-type="bibr">7</xref>].</p>
<p>During the past four decades, attention has been on the potential factor of environmental pollutants such as polychlorinated biphenyls (PCBs), which were classified by the International Agency for Research on Cancer (IARC) in 2013 as carcinogenic to humans (Group 1) on the basis of sufficient evidence of carcinogenicity in humans and experimental animals [<xref rid="pone.0142513.ref008" ref-type="bibr">8</xref>]. PCBs are a class of aromatic compounds comprising 209 congeners, which were widely used as dielectric fluid in capacitors and transformers, and to a lesser extent in building materials. Although PCB production was banned in most countries by the 1980s, PCBs have become ubiquitous environmental pollutants, because of persistence and bioaccumulation [<xref rid="pone.0142513.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0142513.ref010" ref-type="bibr">10</xref>]. They are still found in atmosphere, soil, rivers, lakes, fish, wildlife, animals, and humans. Humans are exposed to PCBs mainly from ingesting PCB-contaminated food (particularly sportfish and wildlife) or from breathing PCB contaminated air [<xref rid="pone.0142513.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0142513.ref012" ref-type="bibr">12</xref>]. Recently, renewed production of PCBs has been reported in the Democratic People’s Republic of Korea [<xref rid="pone.0142513.ref013" ref-type="bibr">13</xref>].</p>
<p>Mass poisonings occurred in Japan in 1968 [<xref rid="pone.0142513.ref014" ref-type="bibr">14</xref>] and in Taiwan in 1979 [<xref rid="pone.0142513.ref015" ref-type="bibr">15</xref>], each involving about two thousand people who had consumed PCB-contaminated cooking oil and then developed symptoms such as fatigue, chloracne, pigmentation of nails, skin, and gums, and hypersecretion of eyelid oil glands. The clinical syndrome was later called Yusho or Yucheng, “oil disease” in Japanese and Chinese, respectively. PCBs potentially target the endocrine system, monohydroxylated PCB metabolites can act as oestrogen agonists or antagonists [<xref rid="pone.0142513.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0142513.ref008" ref-type="bibr">8</xref>]. Worldwide monitoring programmes have shown that PCBs are present in most samples of human milk [<xref rid="pone.0142513.ref017" ref-type="bibr">17</xref>]. These disruptions may have reproductive, toxic, and carcinogenic consequences [<xref rid="pone.0142513.ref018" ref-type="bibr">18</xref>–<xref rid="pone.0142513.ref021" ref-type="bibr">21</xref>]. In 2007, scientists from the Silent Spring Institute reviewed the previous five years of epidemiologic studies of environmental pollutants and breast cancer, and concluded that epidemiologic studies had strengthened the human evidence that PCB exposure plays a role in breast cancer risk [<xref rid="pone.0142513.ref022" ref-type="bibr">22</xref>]. However, the results from epidemiologic studies have been inconsistent. Thus, we conducted a meta-analysis to evaluate the evidence from epidemiologic studies published to date on PCB exposure and the risk of breast cancer by summarizing it quantitatively.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>This study was designed, conducted and reported in adherence to the standards of Meta-analysis of Observational Studies in Epidemiology checklist [<xref rid="pone.0142513.ref023" ref-type="bibr">23</xref>]. Two authors (Zhang and Wu) participated in the literature search, study selection, and data extraction independently, and any disagreement was resolved by consensus.</p>
<sec id="sec007">
<title>Search Strategy</title>
<p>PubMed (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov.pubmed/" xlink:type="simple">http://www.ncbi.nlm.nih.gov.pubmed</ext-link>), EMBASE (<ext-link ext-link-type="uri" xlink:href="https://www.elsevier.com/" xlink:type="simple">https://www.elsevier.com/</ext-link> solutions/embase—biomedical research), CBM (<ext-link ext-link-type="uri" xlink:href="http://libcx.med.stu.edu.cn/" xlink:type="simple">http://libcx.med.stu.edu.cn/</ext-link>) and CNKI (<ext-link ext-link-type="uri" xlink:href="http://epub.cnki.net/kns/default.htm" xlink:type="simple">http://epub.cnki.net/kns/default.htm</ext-link>) were searched for studies published through November 2014. The following keywords were used in searching: “polychlorinated biphenyls or PCBs” and “breast cancer or mammary cancer”. Detailed search terms are provided in the supplementary materials (<xref rid="pone.0142513.s007" ref-type="supplementary-material">S1 Table</xref>). The languages were limited to English and Chinese; no other restrictions were imposed. We also manually searched the reference lists of included articles for original reviews, and searched those for additional relevant studies.</p>
</sec>
<sec id="sec008">
<title>Selection Criteria</title>
<p>Studies were included for statistical analyses if they fulfilled the following criteria: to be observational studies (case-control or cohort studies); to have measured PCB levels in biological samples (adipose tissue, serum or plasma); to have reported measures of association (odds ratio, relative ratio) and 95% confidence intervals (95% CIs) for breast cancer risk. We excluded studies which had no biomarker data; no original data or observations; fewer than 50 breast cancer cases; study subjects were not female; articles were reviews, letters to the editor, editorial reports, case reports, duplicate publications, or abstracts. When there were several articles about the same cohort, the article reporting the largest number of cases was selected. The procedure of study selection is summarized in <xref rid="pone.0142513.g001" ref-type="fig">Fig 1</xref>.</p>
<fig id="pone.0142513.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142513.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flowchart for study selection.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0142513.g001" position="float" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec009">
<title>Data Extraction</title>
<p>The following variables were recorded using data abstraction forms: First author, year of publication, country of study, ages of participants, study period, sample size, study design, specimen type, number of congeners measured, mean exposure level of total PCBs, and variables adjusted for in the analysis. To summarize the main results, we have chosen the measures of total PCB exposure and selected PCB congeners classified as group I (potentially estrogenic), group II (potentially antiestrogenic and immunotoxic, dioxin-like), and group III (phenobarbital, CYP1A and CYP2B inducers, biologically persistent) according to their structural, biological and pharmacokinetics properties proposed by Wolff and Toniolo [<xref rid="pone.0142513.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0142513.ref024" ref-type="bibr">24</xref>]. Group I includes major PCB congeners 44, 49, 52, 101, 174, 177, 187 and 201; group II includes major PCB congeners 66, 74, 77, 105, 118, 126, 128, 138, 156, 167, 169 and 170; group III includes major PCB congeners 99, 153, 180, 183, 196 and 203 [<xref rid="pone.0142513.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0142513.ref024" ref-type="bibr">24</xref>]. Since the articles reported PCB exposure for 3–5 levels, the most fully adjusted OR with corresponding 95% CIs for the highest versus lowest categories were selected in this meta-analysis. The main findings of the selected studies are presented in <xref rid="pone.0142513.t001" ref-type="table">Table 1</xref> and <xref rid="pone.0142513.t002" ref-type="table">Table 2</xref>.</p>
<table-wrap id="pone.0142513.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142513.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of prospective epidemiologic (nested case-control) studies on PCB exposure and breast cancer risk.</title></caption>
<alternatives>
<graphic id="pone.0142513.t001g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0142513.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th rowspan="2" align="left" colspan="1">Study</th>
<th rowspan="2" align="center" colspan="1">Location</th>
<th rowspan="2" align="left" colspan="1">Study Period</th>
<th rowspan="2" align="left" colspan="1">No. of cases: controls</th>
<th rowspan="2" align="left" colspan="1">Age</th>
<th rowspan="2" align="left" colspan="1">No. of measured congeners</th>
<th colspan="2" align="center" rowspan="1">Mean±SD of PCBs (ng/g lipid)</th>
<th rowspan="2" align="center" colspan="1">Adjustment for Covariates</th>
<th rowspan="2" align="left" colspan="1">Biologic Specimen</th>
<th rowspan="2" align="left" colspan="1">Study Quality <xref rid="t001fn005" ref-type="table-fn"><sup>d</sup></xref></th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Cases</th>
<th align="left" rowspan="1" colspan="1">Controls</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Laden et al., 2001</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1976–1994</td>
<td align="left" rowspan="1" colspan="1">370:370</td>
<td align="left" rowspan="1" colspan="1">43–69</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">544 <xref rid="t001fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">543 <xref rid="t001fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">family history of breast cancer, history of BBD, age at menarche, BMI, lipid, number of children, age at birth of first child, lactation.</td>
<td align="left" rowspan="1" colspan="1">plasma</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ward et al., 2000</td>
<td align="left" rowspan="1" colspan="1">Norway</td>
<td align="left" rowspan="1" colspan="1">1973–1991</td>
<td align="left" rowspan="1" colspan="1">150:150</td>
<td align="left" rowspan="1" colspan="1">18–60</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">776.1</td>
<td align="left" rowspan="1" colspan="1">806.6</td>
<td align="left" rowspan="1" colspan="1">lipid concentration in serum.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wolff et al., 2000</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1985–1994</td>
<td align="left" rowspan="1" colspan="1">148:295</td>
<td align="left" rowspan="1" colspan="1">34–65</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">683 (1.64) <xref rid="t001fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">663 (1.62) <xref rid="t001fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">family history of breast cancer, age at menarche, number of children, age at birth of first child, lipid, lactation.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Helzlsouer et al., 1999</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1974–1994</td>
<td align="left" rowspan="1" colspan="1">235:235</td>
<td align="left" rowspan="1" colspan="1">35–70</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">735.3±644.8</td>
<td align="left" rowspan="1" colspan="1">663.6±322.5</td>
<td align="left" rowspan="1" colspan="1">lipid concentration in serum.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Krieger et al., 1994</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1964–1990</td>
<td align="left" rowspan="1" colspan="1">150:150</td>
<td align="left" rowspan="1" colspan="1">45.2(9.6) Mean(SD)</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">4.4±1.8 ng/ml <xref rid="t001fn002" ref-type="table-fn"><sup>a</sup></xref></td>
<td align="left" rowspan="1" colspan="1">4.8±2.5 ng/ml <xref rid="t001fn002" ref-type="table-fn"><sup>a</sup></xref></td>
<td align="left" rowspan="1" colspan="1">BMI, age at menarche, pregnant, menopausal status, race, year of joining program (±1), age and year of multiphasic examination, follow-up time.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dorgan et al., 1999</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1977–1987</td>
<td align="left" rowspan="1" colspan="1">105:208</td>
<td align="left" rowspan="1" colspan="1">47–67</td>
<td align="left" rowspan="1" colspan="1">27</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">age, history of BBD, lipid, year of blood collection.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cohn et al., 2012</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1959–1998</td>
<td align="left" rowspan="1" colspan="1">112:112</td>
<td align="left" rowspan="1" colspan="1">&lt;50</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">0.50 mmol/l <xref rid="t001fn002" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup><xref rid="t001fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">0.43 mmol/l <xref rid="t001fn002" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup><xref rid="t001fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">cholesterol, triglycerides, race, parity, lactation, BMI, year of blood collection.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Høyer et al., 1998</td>
<td align="left" rowspan="1" colspan="1">Denmark</td>
<td align="left" rowspan="1" colspan="1">1976–1995</td>
<td align="left" rowspan="1" colspan="1">240:477</td>
<td align="left" rowspan="1" colspan="1">&gt;20</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td colspan="2" align="center" rowspan="1">1099.89 (547.59) <xref rid="t001fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">age, weight, height, number of children, alcohol, smoking, lipid, physical activity, menopausal status, household income, marital status, education.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Raaschou-Nielsen et al., 2005</td>
<td align="left" rowspan="1" colspan="1">Denmark</td>
<td align="left" rowspan="1" colspan="1">1993–1997</td>
<td align="left" rowspan="1" colspan="1">409:409</td>
<td align="left" rowspan="1" colspan="1">50–64</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">education, BMI, lipid, alcohol, number of children, age at birth of first child, lactation, HRT, history of BBD.</td>
<td align="left" rowspan="1" colspan="1">adipose tissue</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Abbreviations: SD, standard deviation; BBD, benign breast disease; BMI, body mass index; HRT, hormone replacement therapy; NR, not reported.</p></fn>
<fn id="t001fn002"><p>a: Not lipid-adjusted serum concentrations.</p></fn>
<fn id="t001fn003"><p>b: median and/or interquartile range</p></fn>
<fn id="t001fn004"><p>c: geometric mean and/or standard deviation</p></fn>
<fn id="t001fn005"><p>d: Study quality was judged on the basis of the Newcastle-Ottawa Scale (1–9 stars).</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0142513.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142513.t002</object-id>
<label>Table 2</label> <caption><title>Characteristics of retrospective epidemiologic (case-control) studies on PCB exposure and breast cancer risk.</title></caption>
<alternatives>
<graphic id="pone.0142513.t002g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0142513.t002" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th rowspan="2" align="left" colspan="1">Study</th>
<th rowspan="2" align="left" colspan="1">Location</th>
<th rowspan="2" align="left" colspan="1">Study Period</th>
<th rowspan="2" align="left" colspan="1">No. of cases: controls</th>
<th rowspan="2" align="left" colspan="1">Age</th>
<th rowspan="2" align="left" colspan="1">No. of measured congeners</th>
<th colspan="2" align="left" rowspan="1">Mean±SD of PCBs (ng/g lipid)</th>
<th rowspan="2" align="center" colspan="1">Adjustment for Covariates</th>
<th rowspan="2" align="left" colspan="1">Biologic Specimen</th>
<th rowspan="2" align="left" colspan="1">Study Quality <xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref></th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Cases</th>
<th align="left" rowspan="1" colspan="1">Controls</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Zhang et al., 2013</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">2010–2011</td>
<td align="left" rowspan="1" colspan="1">92: 92 (H)</td>
<td align="left" rowspan="1" colspan="1">27–68</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">4.5897 ng/ml <xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup> <xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">2.7683 ng/ml <xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup> <xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">family history of breast cancer, history of BBD, age at menarche, lactation, menstrual cycle, time between menarche and primiparity, bean products intake.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Itoh et al., 2009</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">2001–2005</td>
<td align="left" rowspan="1" colspan="1">403:403 (H)</td>
<td align="left" rowspan="1" colspan="1">20–74</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td align="left" rowspan="1" colspan="1">170 (120–220) <xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">180 (140–240) <xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">age, area, BMI, lipid, menopause, smoking, fish and vegetable consumption, family history of breast cancer, age at first child birth, age at menarche, history of breast cancer screening, lactation.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gatto et al., 2007</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1995–1998</td>
<td align="left" rowspan="1" colspan="1">355:327 (P)</td>
<td align="left" rowspan="1" colspan="1">35–64</td>
<td align="left" rowspan="1" colspan="1">Aroclors 1242, 1260</td>
<td align="left" rowspan="1" colspan="1">310±310</td>
<td align="left" rowspan="1" colspan="1">310±340</td>
<td align="left" rowspan="1" colspan="1">age, BMI, lactation, lipid.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rubin et al., 2006</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1983–1987</td>
<td align="left" rowspan="1" colspan="1">63: 63 (P)</td>
<td align="left" rowspan="1" colspan="1">&gt;45</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">5.30 ng/ml <xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">8.08 ng/ml <xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">parity, family history of breast cancer, race, triglycerides, cholesterol.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Charlier et al., 2004</td>
<td align="left" rowspan="1" colspan="1">Belgium</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">60: 60 (P)</td>
<td align="left" rowspan="1" colspan="1">48–61</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">7.08±7.51 ng/ml <xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref></td>
<td align="left" rowspan="1" colspan="1">5.10±5.15 ng/ml <xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref></td>
<td align="left" rowspan="1" colspan="1">age, age at menarche, menopause, HRT, parity, lactation, family history of breast cancer.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lopez-Carrillo et al., 2002</td>
<td align="left" rowspan="1" colspan="1">Mexico</td>
<td align="left" rowspan="1" colspan="1">1994–1996</td>
<td align="left" rowspan="1" colspan="1">95: 95 (H)</td>
<td align="left" rowspan="1" colspan="1">20–79</td>
<td align="left" rowspan="1" colspan="1">Aroclors 1260</td>
<td align="left" rowspan="1" colspan="1">833 (26–20010.2)<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">833 (26–6078.1)<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">age at menarche, number of children, age at first birth, lactation, lipid, family history of breast cancer, menopausal status, quetelet index.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zheng et al., 2000</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1995–1997</td>
<td align="left" rowspan="1" colspan="1">475: 502 (H, BBD)</td>
<td align="left" rowspan="1" colspan="1">30–80</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">733.1 (706.3–761.0) ng/ml <xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">747.6 (721.0–775.1) ng/ml <xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">BMI, lipid, age at menarche, number of children, age at birth of first child, lactation, HRT, fat intake, family breast cancer history, income, race, study site.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Moysich et al., 1998</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1986–1991</td>
<td align="left" rowspan="1" colspan="1">154:192 (P)</td>
<td align="left" rowspan="1" colspan="1">41–85</td>
<td align="left" rowspan="1" colspan="1">73</td>
<td align="left" rowspan="1" colspan="1">4.29±2.40</td>
<td align="left" rowspan="1" colspan="1">4.12±2.24</td>
<td align="left" rowspan="1" colspan="1">age, education, family history of breast cancer, parity, quetelet index, lactation, age at first birth, years since last pregnancy, fruit and vegetable intake, lipid.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gammon et al., 2002</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1996–1997</td>
<td align="left" rowspan="1" colspan="1">638:423 (P)</td>
<td align="left" rowspan="1" colspan="1">24–96</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">386.72 (1.69) <xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">391.74 (1.74) <xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">age, race, lipid, history of fertility problems, history of BBD.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wolff et al., 2000</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1994–1996</td>
<td align="left" rowspan="1" colspan="1">175: 355 (H, BBD)</td>
<td align="left" rowspan="1" colspan="1">56 (13) <sup>b</sup></td>
<td align="left" rowspan="1" colspan="1">14 (HPCB)</td>
<td align="left" rowspan="1" colspan="1">600 (1.88) <xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">620 (1.86) <xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">age, age-squared, menopausal status, race, BMI, lipid, family history of breast cancer, lactation, parity.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ye et al., 2009</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">2005–2007</td>
<td align="left" rowspan="1" colspan="1">78: 72 (P)</td>
<td align="left" rowspan="1" colspan="1">40–64</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">1.397 (0.047–13.125) ng/ml <xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup> <xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">0.788 (0.096–16.082) ng/ml <xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup> <xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">age, BBD, lactation.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Millikan et al., 2000</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1993–1996</td>
<td align="left" rowspan="1" colspan="1">748: 659 (P)</td>
<td align="left" rowspan="1" colspan="1">21–74</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">age, age-squared, race (all participants), lipid, menopausal status, BMI, parity/lactation, HRT, income.</td>
<td align="left" rowspan="1" colspan="1">plasma</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Demers et al., 2002</td>
<td align="left" rowspan="1" colspan="1">Canada</td>
<td align="left" rowspan="1" colspan="1">1994–1997</td>
<td align="left" rowspan="1" colspan="1">314: 523 (H, P)</td>
<td align="left" rowspan="1" colspan="1">30–70</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">age, region of residence, BMI, lipid, personal history of BBD, lactation.</td>
<td align="left" rowspan="1" colspan="1">plasma</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Stellman et al., 2000</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">1994–1996</td>
<td align="left" rowspan="1" colspan="1">232: 323 (H, BBD)</td>
<td align="left" rowspan="1" colspan="1">&lt;82</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">294.7</td>
<td align="left" rowspan="1" colspan="1">257.1</td>
<td align="left" rowspan="1" colspan="1">age, BMI, lipid, hospital, race.</td>
<td align="left" rowspan="1" colspan="1">adipose tissue</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Aronson et al., 2000</td>
<td align="left" rowspan="1" colspan="1">Canada</td>
<td align="left" rowspan="1" colspan="1">1995–1997</td>
<td align="left" rowspan="1" colspan="1">217:213 (H, BBD)</td>
<td align="left" rowspan="1" colspan="1">&lt;80</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">940 (880–1000) <sup>c</sup></td>
<td align="left" rowspan="1" colspan="1">870 (810–920) <sup>c</sup></td>
<td align="left" rowspan="1" colspan="1">HRT, race, lipid, family history, fat intake, alcohol.</td>
<td align="left" rowspan="1" colspan="1">adipose tissue</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Recio-Vega et al., 2011</td>
<td align="left" rowspan="1" colspan="1">Mexico</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">70: 70 (H)</td>
<td align="left" rowspan="1" colspan="1">25–80</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">5.26 (3.50–7.90) ng/ml <xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup><xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">3.33 (2.37–4.67) ng/ml <xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup><xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">age, age at menarche, lactation, menopausal status, BMI.</td>
<td align="left" rowspan="1" colspan="1">serum</td>
<td align="left" rowspan="1" colspan="1">5</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>Abbreviations: SD, standard deviation; H, hospital control group; P, population control group; BBD, benign breast disease; BMI, body mass index; HRT, hormone replacement therapy; NR, not reported.</p></fn>
<fn id="t002fn002"><p>a: Not lipid-adjusted serum concentrations.</p></fn>
<fn id="t002fn003"><p>b: median and/or interquartile range</p></fn>
<fn id="t002fn004"><p>c: geometric mean and/or standard deviation</p></fn>
<fn id="t002fn005"><p>d: Study quality was judged on the basis of the Newcastle-Ottawa Scale (1–9 stars).</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec010">
<title>Study quality assessment</title>
<p>We assessed study quality by using the nine-star Newcastle-Ottawa Scale (NOS) [<xref rid="pone.0142513.ref025" ref-type="bibr">25</xref>]. The NOS has three dimensions including Selection, Comparability, and Outcome (cohort studies) or Exposure (case-control studies). Response options are provided for each item. A star system (zero to nine stars), is used to allow a semi-quantitative assessment of study quality. Within the Selection and Outcome-Exposure categories, a study can be awarded a maximum of one star for each item. For Comparability, a maximum of two stars can be given. If the study adjusted lipid as the main confounder, we gave one star; if the study adjusted one of the additional confounders like age, body mass index (BMI), lactation, family history of breast cancer or age at menarche, we gave another one star. High-quality studies were defined as having scores ≥8, and moderate quality, scores 5 to 7.</p>
</sec>
<sec id="sec011">
<title>Statistical Analysis</title>
<p>The pooled results were reported as ORs with 95% CIs. For one study [<xref rid="pone.0142513.ref026" ref-type="bibr">26</xref>] that reported results separately for five individual PCB congeners, category-specific ORs, and variances were combined using a fixed-effects model based on inverse variance weight to obtain combined estimates for total PCBs, before estimating the study-specific OR and 95% CI. Statistical heterogeneity in the relationship between PCB exposure and breast cancer among studies was evaluated with Q and <italic>I</italic><sup>2</sup> statistics [<xref rid="pone.0142513.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0142513.ref028" ref-type="bibr">28</xref>]. <italic>I</italic><sup>2</sup> describes the percentage of total variation across studies that is due to heterogeneity rather than chance, which quantifies the effect of heterogeneity of the studies. The range is defined as: <italic>I</italic><sup>2</sup>&lt;25%: low heterogeneity; <italic>I</italic><sup><italic>2</italic></sup> 25–50%: moderate heterogeneity; <italic>I</italic><sup><italic>2</italic></sup>&gt;50% high heterogeneity [<xref rid="pone.0142513.ref029" ref-type="bibr">29</xref>]. Study-specific individual OR estimates were combined based on a fixed-effects model. When heterogeneity was moderate we used a DerSimonian-Laird random-effects model, which considers both within-study and between-study variation [<xref rid="pone.0142513.ref030" ref-type="bibr">30</xref>]. When heterogeneity was high, subgroup analyses were conducted by <italic>a priori</italic> selected variables (study design; type of biological specimen: serum, plasma, or adipose tissue; study location) related to potential effect modifiers to identify sources of heterogeneity.</p>
<p>To explore the stability of the results, several sensitivity analyses were performed, including the influence analysis, in which one study in the meta-analysis was dropped at a time to determine the influence of the individual dataset on the pooled ORs, and meta-analysis excluded the studies which might bring high heterogeneity. Publication bias was assessed visually using funnel plots and statistically using Begg’s test and Egger’s test [<xref rid="pone.0142513.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0142513.ref032" ref-type="bibr">32</xref>]. Statistical significance was considered at P&lt;0.05, two-sided. All statistical analyses were performed using Stata 12 software (Stata Corp, College Station, TX).</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Literature Search</title>
<p>The initial search yielded 660 citations (242 of which were duplicates) from four different databases. After screening the 418 nonduplicated articles based on title and abstract, 92 articles appeared to be potentially relevant for doing full-text screening. We excluded 67 articles for the following reasons: duplicate reports from the same study population (n = 14); articles reporting fewer than 50 breast cancer cases (n = 3); no original data or subjects were not female or articles were editorials, comments, case reports or reviews (n = 50); The remaining 25 articles were evaluated in the study quality assessment step before meta-analysis (<xref rid="pone.0142513.g001" ref-type="fig">Fig 1</xref>).</p>
</sec>
<sec id="sec014">
<title>Study quality</title>
<p>Study quality was assessed based on scoring using the Newcastle-Ottawa Scale, categorized into three dimensions: Selection, Comparability, and Outcome or Exposure. The qualities of the retained 25 studies were moderate to high (5 to 9 stars); the prospective studies met higher quality criteria (7 to 9 stars) than the retrospective studies (5 to 8 stars). The methods and reported data of all included studies were judged to be adequate. The evaluation of quality of included studies is presented in <xref rid="pone.0142513.s010" ref-type="supplementary-material">S4 Table</xref>. Six studies did not adjust the lipid. The quality of prospective epidemiologic (nested case-control) studies was mainly compromised by the low representativeness of the exposed cohort. For the case-control studies, their quality was often compromised by the lack of description for ascertainment of PCB exposure as well as the potential case selection biases and use of hospital controls.</p>
</sec>
<sec id="sec015">
<title>Study Characteristics</title>
<p>A total of 6088 cases in 25 studies published between 1994 and 2013 were analyzed. Of the 25 studies, 14 were conducted in the United States [<xref rid="pone.0142513.ref033" ref-type="bibr">33</xref>–<xref rid="pone.0142513.ref046" ref-type="bibr">46</xref>], two in Canada [<xref rid="pone.0142513.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0142513.ref048" ref-type="bibr">48</xref>], two in China [<xref rid="pone.0142513.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0142513.ref050" ref-type="bibr">50</xref>], two in Denmark [<xref rid="pone.0142513.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0142513.ref052" ref-type="bibr">52</xref>], two in Mexico [<xref rid="pone.0142513.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0142513.ref054" ref-type="bibr">54</xref>], one in Norway [<xref rid="pone.0142513.ref055" ref-type="bibr">55</xref>], one in Japan [<xref rid="pone.0142513.ref056" ref-type="bibr">56</xref>], and one in Belgium [<xref rid="pone.0142513.ref026" ref-type="bibr">26</xref>]. Nine nested case-control prospective studies included 1919 cases [<xref rid="pone.0142513.ref033" ref-type="bibr">33</xref>–<xref rid="pone.0142513.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0142513.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0142513.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0142513.ref055" ref-type="bibr">55</xref>], the remaining 16 case-control retrospective studies included 4169 cases [<xref rid="pone.0142513.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0142513.ref039" ref-type="bibr">39</xref>–<xref rid="pone.0142513.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0142513.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0142513.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0142513.ref056" ref-type="bibr">56</xref>]. Most studies provided risk estimates adjusted for age, body mass index, family history of breast cancer, history of benign breast disease, age at menarche, and lactation. Some studies were adjusted for menopausal status, alcohol, smoking, fish and vegetable consumption, race, or income (<xref rid="pone.0142513.t001" ref-type="table">Table 1</xref>, <xref rid="pone.0142513.t002" ref-type="table">Table 2</xref>).</p>
</sec>
<sec id="sec016">
<title>Associations between PCB exposure and breast cancer</title>
<p>The multivariable-adjusted OR for each study and combination of all studies stratified by study design for the highest versus lowest categories of total PCB exposure and breast cancer risk is shown in <xref rid="pone.0142513.g002" ref-type="fig">Fig 2</xref>. Overall, the summary OR of total PCBs was slightly elevated but not statistically significant and heterogeneity was relatively high (OR = 1.09, 95%CI: 0.97–1.22, <italic>I</italic><sup>2</sup> = 55.4%). There was low heterogeneity among prospective studies (<italic>I</italic><sup>2</sup> = 19.1%), but among retrospective studies the heterogeneity was high (<italic>I</italic><sup>2</sup> = 61.4%).</p>
<fig id="pone.0142513.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142513.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Forest plot describing the association between total PCB exposure and breast cancer risk.</title>
<p>Apart from the overall analysis, the subgroup analyses on prospective (upper panels) and retrospective (lower panels) studies are presented.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0142513.g002" position="float" xlink:type="simple"/>
</fig>
<p>Potentially estrogenic PCBs (Group I) exposure and breast cancer risk are shown in <xref rid="pone.0142513.g003" ref-type="fig">Fig 3</xref>; potentially antiestrogenic and immunotoxic, dioxin-like PCBs (Group II) exposure and breast cancer risk are shown in <xref rid="pone.0142513.g004" ref-type="fig">Fig 4</xref>; phenobarbital, CYP1A and CYP2B inducers, biologically persistent PCBs (Group III) exposure and breast cancer risk are shown in <xref rid="pone.0142513.g005" ref-type="fig">Fig 5</xref>. For potentially estrogenic PCBs (Group I), the association with breast cancer was not significant (OR = 1.10, 95%CI: 0.97–1.24). For group II and group III, the associations with breast cancer were significant, and the heterogeneity was acceptable (<italic>I</italic><sup><italic>2</italic></sup> = 48.0% and <italic>I</italic><sup><italic>2</italic></sup> = 40.2%, respectively). The pooled ORs were 1.23 (95%CI: 1.08–1.40) for group II and 1.25 (95%CI: 1.09–1.43) for group III, respectively. Summary of associations between PCB exposure and breast cancer risk are presented in <xref rid="pone.0142513.s009" ref-type="supplementary-material">S3 Table</xref>.</p>
<fig id="pone.0142513.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142513.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plot describing the association between potentially estrogenic PCBs (Group I) exposure and breast cancer risk.</title>
<p>Apart from the overall analysis, the subgroup analyses on prospective (upper panels) and retrospective (lower panels) studies are presented. (a) Group IB includes PCB congeners 177, 187 and 201; (b) Group IA includes PCB congeners 44, 52; (c) Group IB includes congeners 101, 187.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0142513.g003" position="float" xlink:type="simple"/>
</fig>
<fig id="pone.0142513.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142513.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Forest plot describing the association between potentially antiestrogenic and immunotoxic, dioxin-like PCBs (Group II) exposure and breast cancer risk.</title>
<p>Apart from the overall analysis, the subgroup analyses on prospective (upper panels) and retrospective (lower panels) studies are presented. (a) Group II includes PCB congeners 74, 118, 138, 156 and 170; (b) Group II includes PCB congeners 74, 118, 138, 156, and 170; (c) Group IIA includes congeners 66, 77, 105, 118 and 126; (d) Group IIB includes congeners 128, 138 and 170.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0142513.g004" position="float" xlink:type="simple"/>
</fig>
<fig id="pone.0142513.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142513.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Forest plot describing the association between phenobarbital, CYP1A and CYP2B inducers, biologically persistent PCBs (Group III) exposure and breast cancer risk.</title>
<p>Apart from the overall analysis, the subgroup analyses on prospective (upper panels) and retrospective (lower panels) studies are presented. (a) Group III includes 153, 180 and 183; (b) Group III includes 153, 180, and 183; (c) Group III includes congeners 153 and 180.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0142513.g005" position="float" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>Subgroup analyses for retrospective studies of total PCBs meta-analysis</title>
<p>Subgroup analyses were performed by specimen types and study locations to further explore the sources of the observed high heterogeneity in retrospective studies of total PCBs (<xref rid="pone.0142513.t003" ref-type="table">Table 3</xref>). After stratification by the subgroups, the high degree of heterogeneity still could not be resolved, but the results showed that the heterogeneity was mainly from the studies which used serum specimens or were conducted in Asia. For the North America and Europe subgroups, there appeared statistically significant associations with breast cancer risk and the heterogeneity was low, however, the association was still slightly elevated.</p>
<table-wrap id="pone.0142513.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142513.t003</object-id>
<label>Table 3</label> <caption><title>Subgroup analyses for retrospective studies of total PCBs.</title></caption>
<alternatives>
<graphic id="pone.0142513.t003g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0142513.t003" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th rowspan="2" align="left" colspan="1">Subgroups</th>
<th rowspan="2" align="left" colspan="1">Number of studies</th>
<th rowspan="2" align="left" colspan="1">OR (95% CI)</th>
<th colspan="2" align="left" rowspan="1">Heterogeneity</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1"><italic>I</italic><sup>2</sup> (%)</th>
<th align="left" rowspan="1" colspan="1">P</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Specimen type</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Serum/plasma</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">1.12 (0.95, 1.32)</td>
<td align="left" rowspan="1" colspan="1">66.5</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Adipose tissue</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">1.06 (0.70, 1.60)</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">0.765</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Geographical location</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    North America</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">1.08 (1.01, 1.16)</td>
<td align="left" rowspan="1" colspan="1">2.2</td>
<td align="left" rowspan="1" colspan="1">0.423</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Asia</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">1.91 (0.34, 10.68)</td>
<td align="left" rowspan="1" colspan="1">91.4</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Europe</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">1.15 (1.02, 1.30)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>Abbreviations: NA, not applicable.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec018">
<title>Sensitivity Analysis</title>
<p>Several sensitivity analyses were performed to explore the stability of the results. After one study was removed at a time, we found that the influence of each individual data set on the pooled ORs was not significant (<xref rid="pone.0142513.s002" ref-type="supplementary-material">S1</xref>–<xref rid="pone.0142513.s005" ref-type="supplementary-material">S4</xref> Figs). For the total PCBsn in a meta-analysis excluding three retrospective studies [<xref rid="pone.0142513.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0142513.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0142513.ref056" ref-type="bibr">56</xref>], with divergent odds ratios (Ye [<xref rid="pone.0142513.ref049" ref-type="bibr">49</xref>], OR = 3.00; Zhang et al [<xref rid="pone.0142513.ref050" ref-type="bibr">50</xref>], OR = 7.46; Itoh et al [<xref rid="pone.0142513.ref056" ref-type="bibr">56</xref>], OR = 0.33), the association was slightly attenuated but still not statistically significant (OR = 1.06, 95% CI: 0.98–1.15, <italic>I</italic><sup>2</sup> = 20.7%, P = 0.188) (<xref rid="pone.0142513.s006" ref-type="supplementary-material">S5 Fig</xref>).</p>
</sec>
<sec id="sec019">
<title>Publication Bias</title>
<p>Begg’s test [<xref rid="pone.0142513.ref031" ref-type="bibr">31</xref>] and Egger’s test [<xref rid="pone.0142513.ref032" ref-type="bibr">32</xref>] did not find publication bias among the studies. For total PCBs (Begg’s P = 0.498, Egger’s P = 0.668), for group I (Begg’s P = 0.640, Egger’s P = 0.814), for group II (Begg’s P = 0.302, Egger’s P = 0.658), for group III (Begg’s P = 0.244, Egger’s P = 0.432).</p>
</sec>
</sec>
<sec id="sec020" sec-type="conclusions">
<title>Discussion</title>
<p>We conducted a meta-analysis to evaluate the evidence from epidemiologic studies on PCB congener exposure and the risk of breast cancer. The results showed that the risk of breast cancer was associated with exposure to group II (potentially antiestrogenic and immunotoxic, dioxin-like) and group III PCBs (phenobarbital, CYP1A and CYP2B inducers, biologically persistent) exposure, but not with group I (potentially estrogenic) or total PCB exposure.</p>
<p>In 2013, Zani et al. conducted a meta-analysis of epidemiological studies on cancer risks for exposure to PCBs. Like us, they found no significant association between breast cancer risk and total PCB exposure for highest versus lowest categories (OR = 1.15, 95% CI: 0.92–1.43, <italic>I</italic><sup><italic>2</italic></sup> = 70.6%) [<xref rid="pone.0142513.ref057" ref-type="bibr">57</xref>]. Our study included the articles with the largest number of cases from the same study populations as Zani’s and added two more studies conducted in China which met our selection criteria [<xref rid="pone.0142513.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0142513.ref050" ref-type="bibr">50</xref>]. In addition, since the amounts and proportions of PCB congeners do vary widely from individual to individual, we further explored the relationships with the different PCB congeners grouped by functional significance. Many of the studies included in our meta-analysis did not conduct congener-specific analyses due to some limitations. We identified eight studies for group I congeners, 13 studies for group II, and 11 studies for group III. The selected PCB congeners and ORs of three PCB groups are presented in <xref rid="pone.0142513.s008" ref-type="supplementary-material">S2 Table</xref>. To our knowledge, ours is the first study to quantitatively evaluate the association between PCB congener groups and breast cancer risk, and the results indicate that high exposure to group II and group III PCBs can increase the risk of breast cancer.</p>
<p>For group I PCBs, one suggestion is that the low-persistence PCB congeners may not well reflect the exposure levels at the time of the PCB insult, but rather more recent changes in exposure and intake in breast cancer cases, such as dietary habit change after the diagnosis [<xref rid="pone.0142513.ref058" ref-type="bibr">58</xref>]. For group II PCBs, Wolff et al. stated that the antiestrogenic effects of the PCB congeners could lead to protection against breast cancer [<xref rid="pone.0142513.ref016" ref-type="bibr">16</xref>], which seems to run contrary to current findings. However, some studies also proposed that the dioxin-like effects of the PCB congeners in group II might induce cell differentiation [<xref rid="pone.0142513.ref059" ref-type="bibr">59</xref>], as well as the biotransformation enzymes which in turn affect estradiol metabolism that may increase breast cancer risk [<xref rid="pone.0142513.ref060" ref-type="bibr">60</xref>]. Group III PCBs may influence estradiol metabolism to the more toxic 16-α-hydroxy estradiol and enhance metabolism of carcinogens, and some congeners in this category may also act as hormonal agonists [<xref rid="pone.0142513.ref061" ref-type="bibr">61</xref>]. Some studies showed that CYP1A and CYP1B1 enzyme induction increases the formation of 4-hydroxy-estradiol, a catechol estrogen that damages DNA through the formation of reactive free radicals [<xref rid="pone.0142513.ref062" ref-type="bibr">62</xref>]. Associations between serum levels of POPs, genetic polymorphisms and breast cancer has been observed as well [<xref rid="pone.0142513.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0142513.ref064" ref-type="bibr">64</xref>]. There is some overlap in the ability of PCB congeners to induce enzyme activity. Group III congeners may induce the CYPlAl group to some extent and CYP2A1 may be induced by both group II and III congeners [<xref rid="pone.0142513.ref009" ref-type="bibr">9</xref>]. In addition, groups II and III are classified as heavy congeners, which are associated with disease more frequently, due to their slow metabolism and persistence in the body [<xref rid="pone.0142513.ref053" ref-type="bibr">53</xref>].</p>
<p>For total PCBs, most studies conducted in North America or Europe showed null results, although current levels are likely to be indicative of past exposures because of the long half-lives of the compounds and their resistance to metabolism, years after exposure, the evaluation of risks associated with low levels from a general population sample still could be biased to the null due to non-differential measurement error [<xref rid="pone.0142513.ref033" ref-type="bibr">33</xref>]. Another potential limitation may be that, differences in correlations among PCBs, body mass index (BMI) and PCB half-lives denote different intervals of exposure and rates of elimination across the population. BMI may be a significant factor, causing marked disparities in circulating PCB levels between lean and obese women and leading to inter-individual variations that are not proportional over time. Therefore, although a measurement of persistent PCB levels in the body may reflect lifetime exposure, a single PCB measurement may not accurately represent the past exposure of a population or characterize PCB levels at a time that is relevant to cancer [<xref rid="pone.0142513.ref034" ref-type="bibr">34</xref>]. Since PCBs have shown decreasing trends after the production and use bans came into effect [<xref rid="pone.0142513.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0142513.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0142513.ref066" ref-type="bibr">66</xref>], the different study time periods could have an unintended effect on the results. In our study, for nested case-control studies, most study periods were around the years when PCBs were banned, and they depended on the pre-existence of cohorts that have been followed over time. The information on exposure and sample taken were all collected at baseline before the outcome of interest occurred, and the most appropriate control group was chosen from members of the same cohort who had not developed breast cancer at the time they were chosen. These advantages of the prospective studies may overcome some potential bias in retrospective case control studies, so they could reflect the association between exposure levels and breast cancer risk more adequately. Most case-control studies were conducted many years after PCBs were banned, so they mostly reflect PCB exposure in the past. The long latency could make the time of clinical diagnosis different from the time when breast cancer began to develop, and having control groups from different populations such as communities or hospitals can also bring heterogeneity.</p>
<p>Overall, we observed slightly elevated levels of heterogeneity among the total PCB exposure studies (<italic>I</italic><sup>2</sup> = 55.4%). After stratification by study design, the heterogeneity among prospective studies was low, but among retrospective studies the heterogeneity persisted high. After further stratifying the retrospective studies by specimen-source subgroups, the heterogeneity did not disappear. For the specimen type subgroup, one possible explanation for the heterogeneity is that serum levels can be influenced by factors that relate to the outcome of interest, such as the weight loss experienced by cancer patients at advanced stages, which can mobilize the PCBs stored in the adipose tissue and then increase the serum PCB levels. For the study site subgroup, the heterogeneity among studies in Asia (two in China and one in Japan) was extremely high. However, the North America and European retrospective studies indicated a borderline statistically significant risk for breast cancer associated with PCB exposure and there appeared low heterogeneity among the studies.</p>
<p>There are also several limitations of this meta-analysis. First, one of the included studies conducted by Ye [<xref rid="pone.0142513.ref049" ref-type="bibr">49</xref>] is an unpublished thesis. However, the quality of the study was judged to be adequate (the Newcastle-Ottawa-Scale score was 6). Sensitivity analysis showed this study did not affect the pooled ORs significantly (<xref rid="pone.0142513.s002" ref-type="supplementary-material">S1</xref>–<xref rid="pone.0142513.s005" ref-type="supplementary-material">S4</xref> Figs). We also did meta-analysis without the Ye study, and the results were not changed (data not shown). Second, although most studies adjusted for the common risk factors for breast cancer, there are six studies did not adjust lipid as a main confounder and unknown confounders can’t be excluded as potential explanations for the observed findings. In addition, the definite dose for PCB exposure differed slightly across the studies and the different PCB exposure measurements used in different studies may also bring heterogeneity. Third, it is possible that exposure to mixtures of PCBs and other chemicals with estrogenic properties and other organochlorine pesticides may also affect breast cancer risk. Some in vitro studies suggest that mixtures of complex organochlorine compounds can increase the proliferation of MCF-7 cells due to their estrogenic potential [<xref rid="pone.0142513.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0142513.ref068" ref-type="bibr">68</xref>]. Other studies have shown that the three PCBs most abundant in biological extracts, 2,2',3'4,4',5-hexachlorobiphenyl (PCB138), 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153), and 2,2',3,4,4',5,5'-heptachlorobiphenyl (PCB180) (the single compounds and their mixtures) have pleiotropic effects on the estrogen and androgen receptor. Thus any simple evaluation of the chemical level of the estrogenic, antiestrogenic interaction is complex as the compounds are found in the blood together [<xref rid="pone.0142513.ref069" ref-type="bibr">69</xref>]. Interestingly, studies have extracted the fraction containing the mixture of legacy POPs, including the PCBs, and found a correlation between the chemical level of POP biomarkers and the xenoestrogenicity of the serum POP mixture related to the detected level: the xenoestrogenic activity of the Inuit's (high serum PCB levels) and Warsaw study groups (lower PCB levels) elicited high frequency of samples with ER antagonistic and agonistic activity, respectively. It was suggested that the variation in xenoestrogenic serum activity reflects differences in POP exposure mixture, genetic factors and/or life style factors [<xref rid="pone.0142513.ref070" ref-type="bibr">70</xref>]. Moreover, the xenoestrogenicity and xenoandrogenicity of the extracted fraction of serum legacy POP /PCBs was found to be higher in breast cancer cases, however, only the xenoandrogenicity was significantly related to the risk of breast cancer [<xref rid="pone.0142513.ref071" ref-type="bibr">71</xref>]. Thus, there is a need for further investigation to explore the relationship between mixtures of organochlorine compounds and breast cancer.</p>
<p>Our meta-analysis has several advantages. First, to the best of our knowledge, this is the first meta-analysis that included the studies conducted in China as a developing country, notably, the Chinese studies showing statistically significant strong risk for breast cancer associated with PCB exposure. There are huge differences in amount and mode of exposure between developing and developed countries and there is a dearth of studies to assess the risk of breast cancer in developing countries, which can’t be made up for by generalizing the results from developed countries [<xref rid="pone.0142513.ref072" ref-type="bibr">72</xref>]. Second, we excluded studies [<xref rid="pone.0142513.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0142513.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0142513.ref073" ref-type="bibr">73</xref>] based on fewer than 50 breast cancer cases to minimize small study effects. In these studies, two of them, separately conducted by Liljegren et al. [<xref rid="pone.0142513.ref073" ref-type="bibr">73</xref>] and Bonefeld-Jorgensen et al. [<xref rid="pone.0142513.ref071" ref-type="bibr">71</xref>], found no significant higher risk of breast cancer with total PCB exposure. However, one study conducted by Pavuk et al. [<xref rid="pone.0142513.ref058" ref-type="bibr">58</xref>] found higher serum levels (highest vs. lowest tertile) of total PCBs and PCB congener groups classified by Wolff et al. [<xref rid="pone.0142513.ref024" ref-type="bibr">24</xref>] were inversely associated with risk of breast cancer (<xref rid="pone.0142513.s011" ref-type="supplementary-material">S5 Table</xref>). Third, the quality of included studies was judged to be adequate and the tests did not identify publication bias, which indicates that the pooled result’s bias may be negligible.</p>
</sec>
<sec id="sec021" sec-type="conclusions">
<title>Conclusion</title>
<p>In summary, the results of our meta-analysis based on the observational studies found that the risk of breast cancer was associated with group II and group III PCB exposure, but not with group I or total PCB exposure. Still, more studies in developing countries, and further studies to explore the relationship between mixtures of organochlorine compounds and the risk of breast cancer are needed.</p>
</sec>
<sec id="sec022">
<title>Supporting Information</title>
<supplementary-material id="pone.0142513.s001" xlink:href="info:doi/10.1371/journal.pone.0142513.s001" mimetype="application/msword" position="float" xlink:type="simple">
<label>S1 PRISMA Checklist</label>
<caption>
<title>PRISMA Checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s002" xlink:href="info:doi/10.1371/journal.pone.0142513.s002" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>The result of influence analysis for total PCBs.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s003" xlink:href="info:doi/10.1371/journal.pone.0142513.s003" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>The result of influence analysis for group I PCBs.</title>
<p>(a) Group IB includes PCB congeners 177, 187 and 201; (b) Group IA includes PCB congeners 44,52; (c) Group IB includes congeners 101,187.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s004" xlink:href="info:doi/10.1371/journal.pone.0142513.s004" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>The result of influence analysis for group II PCBs.</title>
<p>(a) Group II includes 74,118,138, 156 and 170; (b) Group II includes PCB congeners 74,118,138,156, and 170; (c) Group IIA includes congeners 66,77,105,118 and 126; (d) Group IIB includes congeners 128,138 and170.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s005" xlink:href="info:doi/10.1371/journal.pone.0142513.s005" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>The result of influence analysis for group III PCBs.</title>
<p>(a) Group III includes 153,180 and 183; (b) Group III includes congeners 153 and 180.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s006" xlink:href="info:doi/10.1371/journal.pone.0142513.s006" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S5 Fig</label>
<caption>
<title>Forest plot of sensitivity analysis describing the association between total PCB exposure and breast cancer risk excluding three retrospective studies.</title>
<p>Apart from the overall analysis, the subgroup analyses on prospective (upper panels) and retrospective (lower panels) studies are presented.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s007" xlink:href="info:doi/10.1371/journal.pone.0142513.s007" mimetype="application/msword" position="float" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Database search strategy.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s008" xlink:href="info:doi/10.1371/journal.pone.0142513.s008" mimetype="application/msword" position="float" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Association between breast cancer risk and PCB congeners grouped according to the classification proposed by Wolff.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s009" xlink:href="info:doi/10.1371/journal.pone.0142513.s009" mimetype="application/msword" position="float" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>Association between PCB exposure and breast cancer risk.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s010" xlink:href="info:doi/10.1371/journal.pone.0142513.s010" mimetype="application/msword" position="float" xlink:type="simple">
<label>S4 Table</label>
<caption>
<title>Evaluation of quality based on the Newcastle-Ottawa scale for the included studies.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0142513.s011" xlink:href="info:doi/10.1371/journal.pone.0142513.s011" mimetype="application/msword" position="float" xlink:type="simple">
<label>S5 Table</label>
<caption>
<title>Characteristics of the excluded studies based on less than 50 breast cancer cases.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0142513.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ferlay</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Soerjomataram</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Dikshit</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Eser</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mathers</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Rebelo</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012</article-title>. <source>Int J Cancer</source>. <year>2015</year>;<volume>136</volume>(<issue>5</issue>):<fpage>E359</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ijc.29210" xlink:type="simple">10.1002/ijc.29210</ext-link></comment> <object-id pub-id-type="pmid">25220842</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parkin</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Bray</surname> <given-names>FI</given-names></name>, <name name-style="western"><surname>Devesa</surname> <given-names>SS</given-names></name>. <article-title>Cancer burden in the year 2000. The global picture</article-title>. <source>Eur J Cancer (Oxford, England: 1990)</source>. <year>2001</year>;<volume>37</volume> <issue>Suppl 8</issue>:<fpage>S4</fpage>–<lpage>66</lpage>.</mixed-citation></ref>
<ref id="pone.0142513.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brody</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Rudel</surname> <given-names>RA</given-names></name>. <article-title>Environmental pollutants and breast cancer</article-title>. <source>Environ Health Perspect</source>. <year>2003</year>;<volume>111</volume>(<issue>8</issue>):<fpage>1007</fpage>. <object-id pub-id-type="pmid">12826474</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salehi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Phillips</surname> <given-names>KP</given-names></name>, <name name-style="western"><surname>Wigle</surname> <given-names>DT</given-names></name>, <name name-style="western"><surname>Krewski</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Aronson</surname> <given-names>KJ</given-names></name>. <article-title>Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors</article-title>. <source>J Toxicol Environ Health B Crit Rev</source>. <year>2008</year>;<volume>11</volume>(<issue>3–4</issue>):<fpage>276</fpage>–<lpage>300</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/10937400701875923" xlink:type="simple">10.1080/10937400701875923</ext-link></comment> <object-id pub-id-type="pmid">18368557</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Olsen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Andersen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dreyer</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Pukkala</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Tryggvadottir</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Verdier</surname> <given-names>MG</given-names></name>, <etal>et al</etal>. <article-title>Summary of avoidable cancers in the Nordic countries</article-title>. <source>APMIS</source>. <year>1997</year>;<volume>105</volume>(<issue>S76</issue>):<fpage>141</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="pone.0142513.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rogan</surname> <given-names>WJ</given-names></name>. <article-title>Pollutants in breast milk</article-title>. <source>Arch Pediatr Adolesc Med</source>. <year>1996</year>;<volume>150</volume>(<issue>9</issue>):<fpage>981</fpage>–<lpage>90</lpage>. <object-id pub-id-type="pmid">8790132</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fredslund</surname> <given-names>SO</given-names></name>, <name name-style="western"><surname>Bonefeld-Jorgensen</surname> <given-names>EC</given-names></name>. <article-title>Breast cancer in the Arctic—changes over the past decades</article-title>. <source>Int J Circumpolar Health</source>. <year>2012</year>;<volume>71</volume>:<fpage>19155</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3402/ijch.v71i0.19155" xlink:type="simple">10.3402/ijch.v71i0.19155</ext-link></comment> <object-id pub-id-type="pmid">22901290</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lauby-Secretan</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Loomis</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Grosse</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ghissassi</surname> <given-names>FE</given-names></name>, <name name-style="western"><surname>Bouvard</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Benbrahim-Tallaa</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls</article-title>. <source>Lancet Oncol</source>. <year>2013</year>;<volume>14</volume>(<issue>4</issue>):<fpage>287</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1470-2045(13)70104-9" xlink:type="simple">10.1016/S1470-2045(13)70104-9</ext-link></comment> <object-id pub-id-type="pmid">23499544</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Safe</surname> <given-names>SH</given-names></name>. <article-title>Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment</article-title>. <source>Crit Rev Toxicol</source>. <year>1994</year>;<volume>24</volume>(<issue>2</issue>):<fpage>87</fpage>–<lpage>149</lpage>. <object-id pub-id-type="pmid">8037844</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Finklea</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Priester</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Creason</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Hauser</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hinners</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hammer</surname> <given-names>D</given-names></name>. <article-title>Polychlorinated biphenyl residues in human plasma expose a major urban pollution problem</article-title>. <source>Am J Public Health</source>. <year>1972</year>;<volume>62</volume>(<issue>5</issue>):<fpage>645</fpage>–<lpage>51</lpage>. <object-id pub-id-type="pmid">4623477</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Annamalai</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Namasivayam</surname> <given-names>V</given-names></name>. <article-title>Endocrine disrupting chemicals in the atmosphere: Their effects on humans and wildlife</article-title>. <source>Environ Int</source>. <year>2015</year>;<volume>76</volume>:<fpage>78</fpage>–<lpage>97</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.envint.2014.12.006" xlink:type="simple">10.1016/j.envint.2014.12.006</ext-link></comment> <object-id pub-id-type="pmid">25569353</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Malisch</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Kotz</surname> <given-names>A</given-names></name>. <article-title>Dioxins and PCBs in feed and food—review from European perspective</article-title>. <source>Sci Total Environ</source>. <year>2014</year>;<volume>491–492</volume>:<fpage>2</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.scitotenv.2014.03.022" xlink:type="simple">10.1016/j.scitotenv.2014.03.022</ext-link></comment> <object-id pub-id-type="pmid">24804623</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref013"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">NIP Korea DPR. The Democratic People’s Republic of Korea National Implementation Plan for the Stockholm Convention on Persistent Organic Pollutants. 2008. Available:<ext-link ext-link-type="uri" xlink:href="http://chm.pops.int/Implementation/NIPs/NIPSubmissions/tabid/253/Default.aspx" xlink:type="simple">http://chm.pops.int/Implementation/NIPs/NIPSubmissions/tabid/253/Default.aspx</ext-link>. Accessed 2014 Jun 10.</mixed-citation></ref>
<ref id="pone.0142513.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuratsune</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yoshimura</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Matsuzaka</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Yamaguchi</surname> <given-names>A</given-names></name>. <article-title>Epidemiologic study on Yusho, a Poisoning Caused by Ingestion of Rice Oil Contaminated with a Commercial Brand of Polychlorinated Biphenyls</article-title>. <source>Environ Health Perspect</source>. <year>1972</year>;<volume>1</volume>:<fpage>119</fpage>–<lpage>28</lpage>. <object-id pub-id-type="pmid">17539070</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsu</surname> <given-names>ST</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>CI</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>NH</given-names></name>, <name name-style="western"><surname>Yeh</surname> <given-names>CC</given-names></name>, <etal>et al</etal>. <article-title>Discovery and epidemiology of PCB poisoning in Taiwan: a four-year followup</article-title>. <source>Environ Health Perspect</source>. <year>1985</year>;<volume>59</volume>:<fpage>5</fpage>–<lpage>10</lpage>. <object-id pub-id-type="pmid">3921364</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolff</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Toniolo</surname> <given-names>PG</given-names></name>. <article-title>Environmental organochlorine exposure as a potential etiologic factor in breast cancer</article-title>. <source>Environ Health Perspect</source>. <year>1995</year>;<volume>103</volume>(<issue>Suppl 7</issue>):<fpage>141</fpage>. <object-id pub-id-type="pmid">8593861</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nyberg</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Winnberg</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Bignert</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bergman</surname> <given-names>A</given-names></name>. <article-title>Spatial and temporal trends of the Stockholm Convention POPs in mothers' milk—a global review</article-title>. <source>Environ Sci Pollut Res Int</source>. <year>2015</year>;<volume>22</volume>(<issue>12</issue>):<fpage>8989</fpage>–<lpage>9041</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11356-015-4080-z" xlink:type="simple">10.1007/s11356-015-4080-z</ext-link></comment> <object-id pub-id-type="pmid">25913228</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pelekanou</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Leclercq</surname> <given-names>G</given-names></name>. <article-title>Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis</article-title>. <source>Int J Dev Biol</source>. <year>2011</year>;<volume>55</volume>(<issue>7</issue>):<fpage>869</fpage>.</mixed-citation></ref>
<ref id="pone.0142513.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brouwer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Longnecker</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Birnbaum</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Cogliano</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kostyniak</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Moore</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs</article-title>. <source>Environ Health Perspect</source>. <year>1999</year>;<volume>107</volume>(<issue>Suppl 4</issue>):<fpage>639</fpage>. <object-id pub-id-type="pmid">10421775</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McKinney</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Waller</surname> <given-names>CL</given-names></name>. <article-title>Polychlorinated biphenyls as hormonally active structural analogues</article-title>. <source>Environ Health Perspect</source>. <year>1994</year>;<volume>102</volume>(<issue>3</issue>):<fpage>290</fpage>. <object-id pub-id-type="pmid">8033869</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fürst</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Fürst</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wilmers</surname> <given-names>K</given-names></name>. <article-title>Human milk as a bioindicator for body burden of PCDDs, PCDFs, organochlorine pesticides, and PCBs</article-title>. <source>Environ Health Perspect</source>. <year>1994</year>;<volume>102</volume>(<issue>Suppl 1</issue>):<fpage>187</fpage>. <object-id pub-id-type="pmid">8187707</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brody</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Moysich</surname> <given-names>KB</given-names></name>, <name name-style="western"><surname>Humblet</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Attfield</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Beehler</surname> <given-names>GP</given-names></name>, <name name-style="western"><surname>Rudel</surname> <given-names>RA</given-names></name>. <article-title>Environmental pollutants and breast cancer</article-title>. <source>Cancer</source>. <year>2007</year>;<volume>109</volume>(<issue>S12</issue>):<fpage>2667</fpage>–<lpage>711</lpage>.</mixed-citation></ref>
<ref id="pone.0142513.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stroup</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Berlin</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Morton</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Olkin</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Williamson</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Rennie</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Meta-analysis of observational studies in epidemiology: a proposal for reporting</article-title>. <source>Jama</source>. <year>2000</year>;<volume>283</volume>(<issue>15</issue>):<fpage>2008</fpage>–<lpage>12</lpage>. <object-id pub-id-type="pmid">10789670</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolff</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Camann</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Gammon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Stellman</surname> <given-names>SD</given-names></name>. <article-title>Proposed PCB congener groupings for epidemiological studies</article-title>. <source>Environ Health Perspect</source>. <year>1997</year>;<volume>105</volume>(<issue>1</issue>):<fpage>13</fpage>. <object-id pub-id-type="pmid">9074863</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref025"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" xlink:type="simple">http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link>. Accessed March 01, 2015.</mixed-citation></ref>
<ref id="pone.0142513.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Charlier</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Albert</surname> <given-names>AI</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Dubois</surname> <given-names>NG</given-names></name>, <name name-style="western"><surname>Plomteux</surname> <given-names>GJ</given-names></name>. <article-title>Polychlorinated biphenyls contamination in women with breast cancer</article-title>. <source>Clin Chim Acta</source>. <year>2004</year>;<volume>347</volume>(<issue>1</issue>):<fpage>177</fpage>–<lpage>81</lpage>.</mixed-citation></ref>
<ref id="pone.0142513.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source>. <year>2002</year>;<volume>21</volume>(<issue>11</issue>):<fpage>1539</fpage>–<lpage>58</lpage>. <object-id pub-id-type="pmid">12111919</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cochran</surname> <given-names>WG</given-names></name>. <article-title>The Combination of Estimates from Different Experiments</article-title>. <source>Biometrics</source>. <year>1954</year>;<volume>10</volume>(<issue>1</issue>):<fpage>101</fpage>–<lpage>29</lpage>.</mixed-citation></ref>
<ref id="pone.0142513.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source>. <year>2003</year>;<volume>327</volume>(<issue>7414</issue>):<fpage>557</fpage>. <object-id pub-id-type="pmid">12958120</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name>. <article-title>Meta-analysis in clinical trials</article-title>. <source>Controlled clinical trials</source>. <year>1986</year>;<volume>7</volume>(<issue>3</issue>):<fpage>177</fpage>–<lpage>88</lpage>. <object-id pub-id-type="pmid">3802833</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source>. <year>1994</year>:<fpage>1088</fpage>–<lpage>101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>;<volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>–<lpage>34</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Laden</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Hankinson</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Wolff</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Colditz</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Willett</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>Speizer</surname> <given-names>FE</given-names></name>, <etal>et al</etal>. <article-title>Plasma organochlorine levels and the risk of breast cancer: An extended follow‐up in the Nurses' Health Study</article-title>. <source>Int J Cancer</source>. <year>2001</year>;<volume>91</volume>(<issue>4</issue>):<fpage>568</fpage>–<lpage>74</lpage>. <object-id pub-id-type="pmid">11251983</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolff</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Zeleniuch-Jacquotte</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dubin</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Toniolo</surname> <given-names>P</given-names></name>. <article-title>Risk of breast cancer and organochlorine exposure</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2000</year>;<volume>9</volume>(<issue>3</issue>):<fpage>271</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">10750665</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Helzlsouer</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Alberg</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Huang H-</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hoffman</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Strickland</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Brock</surname> <given-names>JW</given-names></name>, <etal>et al</etal>. <article-title>Serum concentrations of organochlorine compounds and the subsequent development of breast cancer</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>1999</year>;<volume>8</volume>(<issue>6</issue>):<fpage>525</fpage>–<lpage>32</lpage>. <object-id pub-id-type="pmid">10385143</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krieger</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Wolff</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Hiatt</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Rivera</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Vogelman</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Orentreich</surname> <given-names>N</given-names></name>. <article-title>Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women</article-title>. <source>J Natl Cancer Inst</source>. <year>1994</year>;<volume>86</volume>(<issue>8</issue>):<fpage>589</fpage>–<lpage>99</lpage>. <object-id pub-id-type="pmid">8145274</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dorgan</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Brock</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Rothman</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Needham</surname> <given-names>LL</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Stephenson</surname> <given-names>HE</given-names></name>, <etal>et al</etal>. <article-title>Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA)</article-title>. <source>Cancer Causes Control</source>. <year>1999</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>11</lpage>. <object-id pub-id-type="pmid">10334636</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohn</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Terry</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Plumb</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cirillo</surname> <given-names>PM</given-names></name>. <article-title>Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50</article-title>. <source>Breast Cancer Res Treat</source>. <year>2012</year>;<volume>136</volume>(<issue>1</issue>):<fpage>267</fpage>–<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10549-012-2257-4" xlink:type="simple">10.1007/s10549-012-2257-4</ext-link></comment> <object-id pub-id-type="pmid">23053646</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gatto</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Longnecker</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Press</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Sullivan-Halley</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>McKean-Cowdin</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bernstein</surname> <given-names>L</given-names></name>. <article-title>Serum organochlorines and breast cancer: a case–control study among African-American women</article-title>. <source>Cancer Causes Control</source>. <year>2007</year>;<volume>18</volume>(<issue>1</issue>):<fpage>29</fpage>–<lpage>39</lpage>. <object-id pub-id-type="pmid">17186420</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rubin</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Lanier</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kieszak</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Brock</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Koller</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Strosnider</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Breast cancer among Alaska Native women potentially exposed to environmental organochlorine chemicals</article-title>. <source>Int J Circumpolar Health</source>. <year>2006</year>;<fpage>65</fpage>(1).</mixed-citation></ref>
<ref id="pone.0142513.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stellman</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Djordjevic</surname> <given-names>MV</given-names></name>, <name name-style="western"><surname>Britton</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Muscat</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Citron</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Kemeny</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2000</year>;<volume>9</volume>(<issue>11</issue>):<fpage>1241</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">11097233</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Millikan</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>DeVoto</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Duell</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Tse C-</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Savitz</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Beach</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2000</year>;<volume>9</volume>(<issue>11</issue>):<fpage>1233</fpage>–<lpage>40</lpage>. <object-id pub-id-type="pmid">11097232</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zheng</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Holford</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Mayne</surname> <given-names>ST</given-names></name>, <name name-style="western"><surname>Tessari</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ward</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Carter</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Risk of female breast cancer associated with serum polychlorinated biphenyls and 1, 1-dichloro-2, 2′-bis (p-chlorophenyl) ethylene</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2000</year>;<volume>9</volume>(<issue>2</issue>):<fpage>167</fpage>–<lpage>74</lpage>. <object-id pub-id-type="pmid">10698477</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moysich</surname> <given-names>KB</given-names></name>, <name name-style="western"><surname>Ambrosone</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Vena</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Shields</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Mendola</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Kostyniak</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Environmental organochlorine exposure and postmenopausal breast cancer risk</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>1998</year>;<volume>7</volume>(<issue>3</issue>):<fpage>181</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">9521429</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gammon</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Wolff</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Neugut</surname> <given-names>AI</given-names></name>, <name name-style="western"><surname>Eng</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Teitelbaum</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Britton</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2002</year>;<volume>11</volume>(<issue>8</issue>):<fpage>686</fpage>–<lpage>97</lpage>. <object-id pub-id-type="pmid">12163320</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolff</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Berkowitz</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Brower</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Senie</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bleiweiss</surname> <given-names>IJ</given-names></name>, <name name-style="western"><surname>Tartter</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Organochlorine exposures and breast cancer risk in New York City women</article-title>. <source>Environ Res</source>. <year>2000</year>;<volume>84</volume>(<issue>2</issue>):<fpage>151</fpage>–<lpage>61</lpage>. <object-id pub-id-type="pmid">11068929</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Demers</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ayotte</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Brisson</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Dodin</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Robert</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Dewailly</surname> <given-names>É</given-names></name>. <article-title>Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis</article-title>. <source>Am J Epidemiol</source>. <year>2002</year>;<volume>155</volume>(<issue>7</issue>):<fpage>629</fpage>–<lpage>35</lpage>. <object-id pub-id-type="pmid">11914190</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aronson</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Woolcott</surname> <given-names>CG</given-names></name>, <name name-style="western"><surname>Sterns</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>McCready</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Lickley</surname> <given-names>LA</given-names></name>, <etal>et al</etal>. <article-title>Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2000</year>;<volume>9</volume>(<issue>1</issue>):<fpage>55</fpage>–<lpage>63</lpage>. <object-id pub-id-type="pmid">10667464</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref049"><label>49</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Ye</surname> <given-names>HZ</given-names></name>. <chapter-title>A case-control study on the relationship between organochlorine and breast cancer</chapter-title>: <publisher-name>Zhejiang University</publisher-name>; <year>2009</year>.</mixed-citation></ref>
<ref id="pone.0142513.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Ni</surname> <given-names>W</given-names></name>. <article-title>A case-control study on the relationship between organochlorine and female breast cancer</article-title>. <source>Wei sheng yan jiu = Journal of hygiene research</source>. <year>2013</year>;<volume>42</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">23596706</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Høyer</surname> <given-names>AP</given-names></name>, <name name-style="western"><surname>Grandjean</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Jørgensen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Brock</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Hartvig</surname> <given-names>HB</given-names></name>. <article-title>Organochlorine exposure and risk of breast cancer</article-title>. <source>The Lancet</source>. <year>1998</year>;<volume>352</volume>(<issue>9143</issue>):<fpage>1816</fpage>–<lpage>20</lpage>.</mixed-citation></ref>
<ref id="pone.0142513.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raaschou-Nielsen</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Pavuk</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>LeBlanc</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dumas</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Weber</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Olsen</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2005</year>;<volume>14</volume>(<issue>1</issue>):<fpage>67</fpage>–<lpage>74</lpage>. <object-id pub-id-type="pmid">15668478</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Recio-Vega</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Velazco-Rodriguez</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Ocampo-Gómez</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hernandez-Gonzalez</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ruiz-Flores</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lopez-Marquez</surname> <given-names>F</given-names></name>. <article-title>Serum levels of polychlorinated biphenyls in Mexican women and breast cancer risk</article-title>. <source>J Appl Toxicol</source>. <year>2011</year>;<volume>31</volume>(<issue>3</issue>):<fpage>270</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jat.1672" xlink:type="simple">10.1002/jat.1672</ext-link></comment> <object-id pub-id-type="pmid">21480306</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lopez-Carrillo</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lopez-Cervantes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Torres-Sanchez</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Blair</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Cebrian</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>García</surname> <given-names>R</given-names></name>. <article-title>Serum levels of beta-hexachlorocyclohexane, hexachlorobenzene and polychlorinated biphenyls and breast cancer in Mexican women</article-title>. <source>Eur J Cancer Prev</source>. <year>2002</year>;<volume>11</volume>(<issue>2</issue>):<fpage>129</fpage>–<lpage>35</lpage>. <object-id pub-id-type="pmid">11984130</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ward</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Schulte</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Grajewski</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Andersen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Patterson</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2000</year>;<volume>9</volume>(<issue>12</issue>):<fpage>1357</fpage>–<lpage>67</lpage>. <object-id pub-id-type="pmid">11142422</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Itoh</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Iwasaki</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hanaoka</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kasuga</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yokoyama</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Onuma</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Serum organochlorines and breast cancer risk in Japanese women: a case–control study</article-title>. <source>Cancer Causes Control</source>. <year>2009</year>;<volume>20</volume>(<issue>5</issue>):<fpage>567</fpage>–<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10552-008-9265-z" xlink:type="simple">10.1007/s10552-008-9265-z</ext-link></comment> <object-id pub-id-type="pmid">19031103</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zani</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Toninelli</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Filisetti</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Donato</surname> <given-names>F</given-names></name>. <article-title>Polychlorinated biphenyls and cancer: an epidemiological assessment</article-title>. <source>J Environ Sci Health C</source>. <year>2013</year>;<volume>31</volume>(<issue>2</issue>):<fpage>99</fpage>–<lpage>144</lpage>.</mixed-citation></ref>
<ref id="pone.0142513.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pavuk</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cerhan</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Lynch</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>Kocan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Petrik</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chovancova</surname> <given-names>J</given-names></name>. <article-title>Case-control study of PCBs, other organochlorines and breast cancer in Eastern Slovakia</article-title>. <source>J Expo Anal Environ Epidemiol</source>. <year>2003</year>;<volume>13</volume>(<issue>4</issue>):<fpage>267</fpage>–<lpage>75</lpage>. <object-id pub-id-type="pmid">12923553</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Muto</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Wakui</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Imano</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Nakaaki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hano</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Mammary gland differentiation in female rats after prenatal exposure to 3,3',4,4',5-pentachlorobiphenyl</article-title>. <source>Toxicology</source>. <year>2002</year>;<volume>177</volume>(<issue>2–3</issue>):<fpage>197</fpage>–<lpage>205</lpage>. <object-id pub-id-type="pmid">12135623</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martucci</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Fishman</surname> <given-names>J</given-names></name>. <article-title>P450 enzymes of estrogen metabolism</article-title>. <source>Pharmacol Ther</source>. <year>1993</year>;<volume>57</volume>(<issue>2</issue>):<fpage>237</fpage>–<lpage>57</lpage>.</mixed-citation></ref>
<ref id="pone.0142513.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Soontornchat</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M-H</given-names></name>, <name name-style="western"><surname>Cooke</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Hansen</surname> <given-names>LG</given-names></name>. <article-title>Toxicokinetic and Toxicodynamic Influences on Endocrine Disruption by Polychlorinated Biphenyls</article-title>. <source>Environ Health Perspect</source>. <year>1994</year>;<volume>102</volume>(<issue>6–7</issue>):<fpage>568</fpage>. <object-id pub-id-type="pmid">9679117</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liehr</surname> <given-names>JG</given-names></name>. <article-title>Is Estradiol a Genotoxic Mutagenic Carcinogen? 1</article-title>. <source>Endocrine reviews</source>. <year>2000</year>;<volume>21</volume>(<issue>1</issue>):<fpage>40</fpage>–<lpage>54</lpage>. <object-id pub-id-type="pmid">10696569</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ghisari</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eiberg</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Long</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bonefeld-Jorgensen</surname> <given-names>EC</given-names></name>. <article-title>Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women</article-title>. <source>Environ Health</source>. <year>2014</year>;<volume>13</volume>(<issue>1</issue>):<fpage>19</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1476-069X-13-19" xlink:type="simple">10.1186/1476-069X-13-19</ext-link></comment> <object-id pub-id-type="pmid">24629213</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ghisari</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Long</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bonefeld-Jorgensen</surname> <given-names>EC</given-names></name>. <article-title>Genetic polymorphisms in CYP1A1, CYP1B1 and COMT genes in Greenlandic Inuit and Europeans</article-title>. <source>Int J Circumpolar Health</source>. <year>2013</year>;<volume>72</volume>:<fpage>21113</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3402/ijch.v72i0.21113" xlink:type="simple">10.3402/ijch.v72i0.21113</ext-link></comment> <object-id pub-id-type="pmid">23785672</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Polder</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Thomsen</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lindstrom</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Loken</surname> <given-names>KB</given-names></name>, <name name-style="western"><surname>Skaare</surname> <given-names>JU</given-names></name>. <article-title>Levels and temporal trends of chlorinated pesticides, polychlorinated biphenyls and brominated flame retardants in individual human breast milk samples from Northern and Southern Norway</article-title>. <source>Chemosphere</source>. <year>2008</year>;<volume>73</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.chemosphere.2008.06.002" xlink:type="simple">10.1016/j.chemosphere.2008.06.002</ext-link></comment> <object-id pub-id-type="pmid">18653208</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Konishi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kakimoto</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nagayoshi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Nakano</surname> <given-names>T</given-names></name>. <article-title>Trends in the enantiomeric composition of polychlorinated biphenyl atropisomers in human breast milk</article-title>. <source>Environ Sci Pollut Res Int</source>. <year>2015</year>.</mixed-citation></ref>
<ref id="pone.0142513.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aubé</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Larochelle</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ayotte</surname> <given-names>P</given-names></name>. <article-title>Differential effects of a complex organochlorine mixture on the proliferation of breast cancer cell lines</article-title>. <source>Environ Res</source>. <year>2011</year>;<volume>111</volume>(<issue>3</issue>):<fpage>337</fpage>–<lpage>47</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.envres.2011.01.010" xlink:type="simple">10.1016/j.envres.2011.01.010</ext-link></comment> <object-id pub-id-type="pmid">21295777</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonefeld-Jorgensen</surname> <given-names>EC</given-names></name>, <name name-style="western"><surname>Ghisari</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wielsoe</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bjerregaard-Olesen</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kjeldsen</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Long</surname> <given-names>M</given-names></name>. <article-title>Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo</article-title>. <source>Basic Clin Pharmacol Toxicol</source>. <year>2014</year>;<volume>115</volume>(<issue>1</issue>):<fpage>118</fpage>–<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/bcpt.12263" xlink:type="simple">10.1111/bcpt.12263</ext-link></comment> <object-id pub-id-type="pmid">24797035</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonefeld-Jorgensen</surname> <given-names>EC</given-names></name>, <name name-style="western"><surname>Andersen</surname> <given-names>HR</given-names></name>, <name name-style="western"><surname>Rasmussen</surname> <given-names>TH</given-names></name>, <name name-style="western"><surname>Vinggaard</surname> <given-names>AM</given-names></name>. <article-title>Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity</article-title>. <source>Toxicology</source>. <year>2001</year>;<volume>158</volume>(<issue>3</issue>):<fpage>141</fpage>–<lpage>53</lpage>. <object-id pub-id-type="pmid">11275356</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonefeld-Jorgensen</surname> <given-names>EC</given-names></name>, <name name-style="western"><surname>Hjelmborg</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Reinert</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>Andersen</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Lesovoy</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Lindh</surname> <given-names>CH</given-names></name>, <etal>et al</etal>. <article-title>Xenoestrogenic activity in blood of European and Inuit populations</article-title>. <source>Environ Health</source>. <year>2006</year>;<volume>5</volume>:<fpage>12</fpage>. <object-id pub-id-type="pmid">16674832</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonefeld-Jorgensen</surname> <given-names>EC</given-names></name>, <name name-style="western"><surname>Long</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bossi</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ayotte</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Asmund</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kruger</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study</article-title>. <source>Environ Health</source>. <year>2011</year>;<volume>10</volume>:<fpage>88</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1476-069X-10-88" xlink:type="simple">10.1186/1476-069X-10-88</ext-link></comment> <object-id pub-id-type="pmid">21978366</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shakeel</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>George</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Jose</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Jose</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mathew</surname> <given-names>A</given-names></name>. <article-title>Pesticides and breast cancer risk: a comparison between developed and developing countries</article-title>. <source>Asian Pac J Cancer Prev</source>. <year>2010</year>;<volume>11</volume>(<issue>1</issue>):<fpage>173</fpage>–<lpage>80</lpage>. <object-id pub-id-type="pmid">20593953</object-id></mixed-citation></ref>
<ref id="pone.0142513.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liljegren</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hardell</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lindstrom</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Dahl</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Magnuson</surname> <given-names>A</given-names></name>. <article-title>Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene</article-title>. <source>Eur J Cancer Prev</source>. <year>1998</year>;<volume>7</volume>(<issue>2</issue>):<fpage>135</fpage>–<lpage>40</lpage>. <object-id pub-id-type="pmid">9818775</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>